DaVita®, the kidney care division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced an agreement to provide certain pharmacy services to Fresenius Medical Care (FMC).
FMC, a leading provider of dialysis services and maker of dialysis products, will use DaVita Rx® prescription drug services for its Medicare patients in the United States.
Congress required that beginning in 2011, some oral medications will be included in the bundled payment model. By 2016 all oral end stage renal disease medications will be included in the bundled payment. FMC’s contract with DaVita Rx will help implement that requirement by using DaVita Rx’s state-of–the-art pharmacy to fill and ship oral medications to FMC Medicare patients. DaVita Rx service for FMC will begin in late 2013.
“Fresenius Medical Care is committed to providing the best and most efficient care for renal patients,” said Ronald Kuerbitz, chief executive officer of Fresenius Medical Care North America. “The effectiveness and efficiency of our renal pharmacy management program is critical to meeting that commitment, by helping dialysis patients and physicians coordinate the dietary, pharmacy and dialysis components of their therapy, wherever they are. By accessing DaVita’s substantial investment in pharmacy capabilities, we can more efficiently use our resources to enhance other elements of our network and advance best practices in renal care.”DaVita Rx is the first and largest full-service pharmacy created specifically for the unique needs of kidney patients. By delivering not only all renal-related medications, but also all other prescribed medications to patients’ homes or dialysis centers, DaVita Rx helps patients improve compliance with their required drug regimens, resulting in healthier patients and improved quality of life. DaVita Rx also partners with care providers to advocate for patients with insurance companies and has pharmacists trained in renal care available 24 hours per day, seven days per week. DaVita Rx has served the prescription drug needs of patients receiving dialysis from DaVita and other dialysis providers since 2005.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts